Placebo to ARGX-117 IV concentrate solution for infusion, ARGX-117
ARGX-117-2301
Phase 2 small_molecule active
Quick answer
Placebo to ARGX-117 IV concentrate solution for infusion, ARGX-117 for Myositis, Dermatomyositis is a Phase 2 program (small_molecule) at Argenx with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Argenx
- Indication
- Myositis, Dermatomyositis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active